Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Deficit)

v3.21.1
Condensed Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Equity Payable [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 51,381 $ 100,862 $ 94,781,738 $ 8,780 $ (96,657,106) $ (1,714,345)
Beginning balance, shares at Dec. 31, 2019 51,380,969          
Issuance of common stock for warrants conversion $ 235   234,265     234,500
Issuance of common stock for warrants conversion, Shares 234,500          
Stock based compensation     199,213     199,213
Foreign currency translation adjustment       (13,081)   (13,081)
Net loss         (1,015,779) (1,015,779)
Ending balance, value at Mar. 31, 2020 $ 51,616 100,862 95,215,216 (4,301) (97,672,885) (2,309,492)
Ending balance, shares at Mar. 31, 2020 51,615,469          
Beginning balance, value at Dec. 31, 2019 $ 51,381 100,862 94,781,738 8,780 (96,657,106) $ (1,714,345)
Beginning balance, shares at Dec. 31, 2019 51,380,969          
Issuance of common stock for options exercised, Shares           15,000
Ending balance, value at Dec. 31, 2020 $ 55,411 100,862 101,186,889 (23,446) (99,575,503) $ 1,744,213
Ending balance, shares at Dec. 31, 2020 55,410,695          
Stock based compensation     228,623     228,623
Foreign currency translation adjustment       (9,678)   (9,678)
Net loss         (1,693,773) (1,693,773)
Ending balance, value at Mar. 31, 2021 $ 55,411 $ 100,862 $ 101,415,512 $ (33,124) $ (101,269,276) $ 269,385
Ending balance, shares at Mar. 31, 2021 55,410,695